April
29
 

Convicted rapist next in line for organ transplant

pike

Convicted rapist Kenneth Pike, of New York, was expected to undergo a life-saving heart transplant that could have cost as much as US$800,000, a price that would have been funded by taxpayers. The expense angered several crime victim advocates and community members, who said they could not understand how the justice system can provide expensive services for convicted felons arguably at innocent patients’ expense. Pike ultimately turned down the transplant, but some significant bioethical questions remain. Should taxpayers bear the financial brunt of medical treatment for convicted criminals, especially if those taxpayers are struggling to pay their own medical bills?

“From a moral standpoint I think everyone should have a chance at life,” said Carol Speach, a media sales professional in Auburn, N.Y. “But realistically, I think no he shouldn't. I know innocent people with health problems who have medical bills coming out of their ears and can't afford it.”   

Bioethicist Art Caplan, of the University of Pennsylvania, said transplant centres have the right to turn away patients, but doctors are required to care for every patient they see. While transplant lists do not list a patient’s criminal histories, or whether the recipient is currently in prison, Caplan said there have not been many cases of prisoners approved for organ donations. “In general, the ethics of medicine is not to sort out sinners and saints,” he said.ABC News, Apr 26



comments powered by Disqus
 

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed


 Recent Posts
Poland’s high court effectively bans abortion
24 Oct 2020
‘Medical aid in dying’ saves money: Canadian report
24 Oct 2020
IVF doctors up in arms over Trump’s SCOTUS pick
24 Oct 2020
Let’s return to the basics of human experience, says bioethicist
24 Oct 2020
What factors can undermine our autonomy?
24 Oct 2020

Home | About Us | Contact Us | Privacy Policy | rss RSS | Archive | Bookmark and Share | michael@bioedge.org

BioEdge - New Media Foundation Ltd © 2004 - 2019